Penumbra
PEN
Performance
About Penumbra
Penumbra is a global healthcare company focused on innovating novel medical technologies to improve patient outcomes. The company develops neurovascular and vascular interventional devices for ischemic stroke and other cerebrovascular and vascular conditions, with operations and markets spanning internationally. Its portfolio includes devices for reperfusion, embolization, and vascular access, and the organization emphasizes research, clinical evidence, and patient impact. Penumbra’s content indicates a US-centric audience with a presence in multiple regions and a commitment to advancing interventional neuroradiology and vascular therapies.
Recent News
PharmaShots Quarterly Outlook: The Forces Reshaping Biopharma in Q1 2026
Biotech’s Next Chapter: Asset-Centric Deals and Shifting Alpha at JPM 2026
Boston Scientific to Acquire Penumbra for $14.5B
E2 Raises $80M to Market Thrombectomy Platform
Bank of America Beats Profit Forecasts as Trading, Investment Banking Drive Growth
Recent Deals
No recent deals for this company.